Greg Hough

4.7k total citations · 1 hit paper
41 papers, 3.7k citations indexed

About

Greg Hough is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Greg Hough has authored 41 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 12 papers in Molecular Biology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Greg Hough's work include Cholesterol and Lipid Metabolism (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Lipoproteins and Cardiovascular Health (7 papers). Greg Hough is often cited by papers focused on Cholesterol and Lipid Metabolism (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Lipoproteins and Cardiovascular Health (7 papers). Greg Hough collaborates with scholars based in United States, Russia and Canada. Greg Hough's co-authors include Mohamad Navab, Alan M. Fogelman, Susan Hama, Srinivasa T. Reddy, Benjamin J. Ansell, David W. Garber, Víctor Grijalva, G.M. Anantharamaiah, Gregg C. Fonarow and Brian J. Van Lenten and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Greg Hough

41 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL

2004 546 citations Mohamad Navab, Srinivasa T. Reddy et al. Journal of Lipid Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Greg Hough United States	26	1.7k	1.3k	982	678	614	41	3.7k
Jerzy–Roch Nofer Germany	36	2.0k 1.2×	1.3k 1.1×	2.0k 2.0×	628 0.9×	608 1.0×	104	5.0k
Joan Carles Escolà‐Gil Spain	35	1.7k 1.0×	906 0.7×	1.5k 1.6×	810 1.2×	485 0.8×	151	4.1k
John R. Burnett Australia	36	2.5k 1.5×	1.3k 1.0×	1.3k 1.3×	694 1.0×	256 0.4×	164	4.6k
Lawrence W. Castellani United States	41	1.8k 1.1×	1.3k 1.0×	2.2k 2.2×	541 0.8×	804 1.3×	71	6.6k
Saša Frank Austria	34	1.0k 0.6×	611 0.5×	1.1k 1.1×	451 0.7×	313 0.5×	98	3.1k
Zac Varghese United Kingdom	40	1.5k 0.9×	888 0.7×	1.5k 1.5×	714 1.1×	656 1.1×	130	5.4k
Suzanne Lussier‐Cacan Canada	33	1.6k 1.0×	1.1k 0.9×	668 0.7×	414 0.6×	105 0.2×	82	3.8k
John F. Moorhead United Kingdom	35	1.1k 0.6×	615 0.5×	1.2k 1.3×	613 0.9×	663 1.1×	71	3.9k
Diego Gómez‐Coronado Spain	27	996 0.6×	520 0.4×	1.0k 1.0×	541 0.8×	273 0.4×	80	2.8k
Uwe J.F. Tietge Netherlands	49	3.0k 1.8×	2.1k 1.6×	2.4k 2.4×	891 1.3×	935 1.5×	187	7.5k

Countries citing papers authored by Greg Hough

Since Specialization

Citations

This map shows the geographic impact of Greg Hough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Hough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Hough more than expected).

Fields of papers citing papers by Greg Hough

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Hough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Hough. The network helps show where Greg Hough may publish in the future.

Co-authorship network of co-authors of Greg Hough

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Hough. A scholar is included among the top collaborators of Greg Hough based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Hough. Greg Hough is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hough, Greg, et al.. (2023). 153P Discovery of a novel, dual CD73 and PD-1 targeting multispecific drug Fc-conjugate (DFC) for the treatment of cancer. Immuno-Oncology Technology. 20. 100664–100664. 1 indexed citations

Hough, Greg, A. Chattopadhyay, Mohamad Navab, et al.. (2017). Transgenic tomatoes expressing the 6F peptide and ezetimibe prevent diet-induced increases of IFN-β and cholesterol 25-hydroxylase in jejunum. Journal of Lipid Research. 58(8). 1636–1647. 12 indexed citations

Chattopadhyay, A., Mohamad Navab, Greg Hough, et al.. (2016). Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD. Journal of Lipid Research. 57(5). 832–847. 21 indexed citations

Navab, Mohamad, A. Chattopadhyay, Greg Hough, et al.. (2015). Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis. Journal of Lipid Research. 56(4). 871–887. 41 indexed citations

Navab, Kaveh, et al.. (2014). Systemic Inflammation, Intestine, and Paraoxonase-1. Advances in experimental medicine and biology. 824. 83–88. 7 indexed citations

Kim, Juyong Brian, Susan Hama, Greg Hough, et al.. (2013). Heart Failure is Associated With Impaired Anti-Inflammatory and Antioxidant Properties of High-Density Lipoproteins. The American Journal of Cardiology. 112(11). 1770–1777. 34 indexed citations

Chattopadhyay, A., Mohamad Navab, Greg Hough, et al.. (2013). A novel approach to oral apoA-I mimetic therapy. Journal of Lipid Research. 54(4). 995–1010. 73 indexed citations

Navab, Mohamad, Greg Hough, Georgette M. Buga, et al.. (2013). Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid. Journal of Lipid Research. 54(12). 3403–3418. 58 indexed citations

Li, Rongsong, Mohamad Navab, Payam Pakbin, et al.. (2013). Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice. Journal of Lipid Research. 54(6). 1608–1615. 89 indexed citations

10.

Navab, Mohamad, Srinivasa T. Reddy, Brian J. Van Lenten, et al.. (2012). High-Density Lipoprotein and 4F Peptide Reduce Systemic Inflammation by Modulating Intestinal Oxidized Lipid Metabolism. Arteriosclerosis Thrombosis and Vascular Biology. 32(11). 2553–2560. 57 indexed citations

11.

Navab, Mohamad, Srinivasa T. Reddy, G.M. Anantharamaiah, et al.. (2011). D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice. Journal of Lipid Research. 53(3). 437–445. 49 indexed citations

12.

Navab, Mohamad, Srinivasa T. Reddy, G.M. Anantharamaiah, et al.. (2011). Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally. Journal of Lipid Research. 52(6). 1200–1210. 55 indexed citations

13.

Meriwether, David, Satoshi Imaizumi, Víctor Grijalva, et al.. (2011). Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma. Journal of Lipid Research. 52(10). 1795–1809. 13 indexed citations

14.

Watson, Catherine E., Lise Kjems, Surya Ayalasomayajula, et al.. (2010). Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function. Journal of Lipid Research. 52(2). 361–373. 126 indexed citations

15.

Navab, Mohamad, Piotr Ruchała, Alan J. Waring, et al.. (2009). A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids. Journal of Lipid Research. 50(8). 1538–1547. 50 indexed citations

16.

Hama, Susan, et al.. (2009). The Effect of HDL Mimetic Peptide 4F on PON1. Advances in experimental medicine and biology. 660. 167–172. 13 indexed citations

17.

Navab, Mohamad, Srinivasa T. Reddy, Brian J. Van Lenten, et al.. (2005). The double jeopardy of HDL. Annals of Medicine. 37(3). 173–178. 116 indexed citations

18.

Navab, Mohamad, Srinivasa T. Reddy, Brian J. Van Lenten, et al.. (2004). Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. Journal of Lipid Research. 45(6). 993–1007. 546 indexed citations breakdown →

19.

Dwyer, James H., Mohamad Navab, Kathleen M. Dwyer, et al.. (2001). Oxygenated Carotenoid Lutein and Progression of Early Atherosclerosis. Circulation. 103(24). 2922–2927. 270 indexed citations

20.

Hough, Greg, et al.. (1996). Lie as Narrative Truth in Abused Adopted Adolescents. The Psychoanalytic Study of the Child. 51(1). 580–596. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact